{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:13:54Z","timestamp":1771046034042,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T00:00:00Z","timestamp":1411430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2466-14-150","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T11:01:37Z","timestamp":1411470097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Rosa Maria","family":"Gir\u00f3n-Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L","family":"Justicia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Mar","family":"G\u00f3mez-Punter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda","family":"Fernandes-Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Ancochea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,23]]},"reference":[{"key":"591_CR1","volume-title":"(Eds): Tratado de Fibrosis Qu\u00edstica","author":"A Salcedo Posadas","year":"2012","unstructured":"Salcedo Posadas A, Gartner S, Gir\u00f3n Moreno RM, Garc\u00eda Novo MD: (Eds): Tratado de Fibrosis Qu\u00edstica. 2012, Madrid: Editorial Justim SL"},{"key":"591_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1164\/rccm.200202-087OC","volume":"166","author":"N Mayer-Hamblett","year":"2002","unstructured":"Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss CH, Aitken ML: Developingcystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med. 2002, 166: 1550-1555. 10.1164\/rccm.200202-087OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"591_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.rmed.2008.09.024","volume":"103","author":"A Amadori","year":"2009","unstructured":"Amadori A, Antonelli A, Balteri I, Schreiber A, Bugiani M, De Rose V: Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis. Respir Med. 2009, 103: 407-413. 10.1016\/j.rmed.2008.09.024.","journal-title":"Respir Med"},{"key":"591_CR4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1136\/thx.2011.161117","volume":"66","author":"K de Boer","year":"2011","unstructured":"de Boer K, Vandemheen KL, Tullis E, Doucette S, Fergusson D, Freitag A, Paterson N, Jackson M, Lougheed MD, Kumar V, Aaron SD: Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011, 66: 680-5. 10.1136\/thx.2011.161117.","journal-title":"Thorax"},{"key":"591_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJM199409083311003","volume":"331","author":"HJ Fuchs","year":"1994","unstructured":"Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME: Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994, 331: 637-42. 10.1056\/NEJM199409083311003.","journal-title":"N Engl J Med"},{"key":"591_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/ppul.1072","volume":"31","author":"C Dakin","year":"2001","unstructured":"Dakin C, Henry RL, Field P, Morton J: Defining an exacerbation of pulmonary disease in cystic fibrosis. Pediatr Pulmonol. 2001, 31: 436-442. 10.1002\/ppul.1072.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"591_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/thx.2006.060889","volume":"62","author":"CH Goss","year":"2007","unstructured":"Goss CH, Burns JL: Exacerbations in cystic fibrosis-1: epidemiology and pathogenesis. Thorax. 2007, 62 (4): 360-367. 10.1136\/thx.2006.060889.","journal-title":"Thorax"},{"key":"591_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/01.mcp.0000245711.43891.16","volume":"12","author":"A Smyth","year":"2006","unstructured":"Smyth A: Update on treatment of pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med. 2006, 12: 440-444. 10.1097\/01.mcp.0000245711.43891.16.","journal-title":"Curr Opin Pulm Med"},{"key":"591_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1136\/thx.2006.060897","volume":"62","author":"SC Bell","year":"2007","unstructured":"Bell SC, Robinson PJ: Exacerbations in cystic fibrosis: 2. prevention. Thorax. 2007, 62: 723-732. 10.1136\/thx.2006.060897.","journal-title":"Thorax"},{"key":"591_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/thx.2006.060905","volume":"63","author":"A Smyth","year":"2008","unstructured":"Smyth A, Elborn JS: Exacerbations in cystic fibrosis: 3. management. Thorax. 2008, 63: 180-184.","journal-title":"Thorax"},{"key":"591_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1067\/mpd.2001.117288","volume":"139","author":"M Rosenfeld","year":"2001","unstructured":"Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, Ramsey B: Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr. 2001, 139: 359-65. 10.1067\/mpd.2001.117288.","journal-title":"J Pediatr"},{"key":"591_CR12","volume-title":"Annual Data Report Bethesda, Maryland \u00a92013","author":"Cystic Fibrosis Foundation Patient Registry","year":"2012","unstructured":"Cystic Fibrosis Foundation Patient Registry: Annual Data Report Bethesda, Maryland \u00a92013. 2012, Cystic Fibrosis: Foundation"},{"issue":"2","key":"591_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jpeds.2005.10.019","volume":"148","author":"T Ferkol","year":"2006","unstructured":"Ferkol T, Rosenfeld M, Milla CE: Cystic fibrosis pulmonary exacerbations. J Pediatr. 2006, 148 (2): 259-264. 10.1016\/j.jpeds.2005.10.019.","journal-title":"J Pediatr"},{"key":"591_CR14","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/S1569-1993(11)60012-X","volume":"10 Suppl 2","author":"D Bilton","year":"2011","unstructured":"Bilton D, Canny G, Conway S, Dumcius S, Hjelte L, Proesmans M, T\u00fcmmler B, Vavrova V, De Boeck K: Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros. 2011, 10 Suppl 2: S79-81.","journal-title":"J Cyst Fibros"},{"issue":"9","key":"591_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","volume":"180","author":"PA Flume","year":"2009","unstructured":"Flume PA, Mogayzel PJ, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC: Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med. 2009, 180 (9): 802-808. 10.1164\/rccm.200812-1845PP.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"591_CR16","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1378\/chest.13-0693","volume":"144","author":"A Hakimi Shoki","year":"2013","unstructured":"Hakimi Shoki A, Mayer-Hamblett N, Wilcox P, Sin D, Quon B: Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations. Chest. 2013, 144 (5): 1659-1670. 10.1378\/chest.13-0693.","journal-title":"Chest"},{"issue":"5","key":"591_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jcf.2009.06.001","volume":"8","author":"M Roderfeld","year":"2009","unstructured":"Roderfeld M, Rath T, Schulz R, Seeger W, Tschuschner A, Graf J, Roeb E: Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation. J Cyst Fibros. 2009, 8 (5): 338-47. 10.1016\/j.jcf.2009.06.001.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"591_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/MBC.0b013e3283249ac6","volume":"20","author":"SJ Davidson","year":"2009","unstructured":"Davidson SJ, Paramothayan S, Hodson ME: Adult cystic fibrosis patients with and without infective exacerbations and their factor XII levels. Blood Coagul Fibrinolysis. 2009, 20 (6): 400-402. 10.1097\/MBC.0b013e3283249ac6.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"591_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1034\/j.1399-3003.1999.14b32.x","volume":"14","author":"J Hendry","year":"1999","unstructured":"Hendry J, Elborn JS, Nixon L, Shale DJ, Webb AK: Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa. Eur Respir J. 1999, 14 (2): 435-438.","journal-title":"Eur Respir J"},{"issue":"2","key":"591_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0954-6111(06)80292-1","volume":"85","author":"RJ Rayner","year":"1991","unstructured":"Rayner RJ, Wiseman MS, Cordon SM, Norman D, Hiller EJ, Shale DJ: Inflammatory markers in cystic fibrosis. Respir Med. 1991, 85 (2): 139-145. 10.1016\/S0954-6111(06)80292-1.","journal-title":"Respir Med"},{"issue":"5","key":"591_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1183\/09031936.99.14511459","volume":"14","author":"I Eichler","year":"1999","unstructured":"Eichler I, Nilsson M, Rath R, Enander I, Venge P, Koller DY: Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis. Eur Respir J. 1999, 14 (5): 1145-1149. 10.1183\/09031936.99.14511459.","journal-title":"Eur Respir J"},{"issue":"1","key":"591_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ppul.1950170103","volume":"17","author":"SL Watkin","year":"1994","unstructured":"Watkin SL, Elborn JS, Cordon SM, Hiller EJ, Shale DJ: C-reactive protein is not a useful indicator of intermittent bacterial colonization in early lung disease of patients with cystic fibrosis. Pediatr Pulmonol. 1994, 17 (1): 6-10. 10.1002\/ppul.1950170103.","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"591_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/thx.49.8.803","volume":"49","author":"D Peckham","year":"1994","unstructured":"Peckham D, Crouch S, Humphreys H, Lobo B, Tse A, Knox AJ: Effect of antibiotic treatment on inflammatory markers and lung function in cystic fibrosis patients with Pseudomonas cepacia. Thorax. 1994, 49 (8): 803-807. 10.1136\/thx.49.8.803.","journal-title":"Thorax"},{"issue":"4","key":"591_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1479972312445903","volume":"9","author":"IM Sequeiros","year":"2012","unstructured":"Sequeiros IM, Jarad NA: Extending the course of intravenous antibiotics in adult patients with cystic fibrosis with acute pulmonary exacerbations. Chron Respir Dis. 2012, 9 (4): 213-220. 10.1177\/1479972312445903.","journal-title":"Chron Respir Dis"},{"issue":"3","key":"591_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jcf.2010.01.005","volume":"9","author":"RD Gray","year":"2010","unstructured":"Gray RD, Imrie M, Boyd AC, Porteous D, Innes JA, Greening AP: Sputum and serum calprotectin are useful biomarkers during CF exacerbation. J Cyst Fibros. 2010, 9 (3): 193-198. 10.1016\/j.jcf.2010.01.005.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"591_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1479972311433575","volume":"9","author":"IM Sequeiros","year":"2012","unstructured":"Sequeiros IM, Jarad N: Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis. Chron Respir Dis. 2012, 9 (1): 9-16. 10.1177\/1479972311433575.","journal-title":"Chron Respir Dis"},{"issue":"6 Pt 1","key":"591_CR27","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1164\/ajrccm.157.6.9704086","volume":"157","author":"LS Nixon","year":"1998","unstructured":"Nixon LS, Yung B, Bell SC, Elborn JS, Shale DJ: Circulating immunoreactive interleukin-6 in cystic fibrosis. Am J Respir Crit Care Med. 1998, 157 (6 Pt 1): 1764-1769.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"591_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0954-6111(05)80263-X","volume":"87","author":"JS Elborn","year":"1993","unstructured":"Elborn JS, Cordon SM, Parker D, Delamere FM, Shale DJ: The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection. Respir Med. 1993, 87 (8): 603-607. 10.1016\/S0954-6111(05)80263-X.","journal-title":"Respir Med"},{"issue":"3","key":"591_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1651-2227.1992.tb12209.x","volume":"81","author":"EA Valletta","year":"1992","unstructured":"Valletta EA, Rigo A, Bonazzi L, Zanolla L, Mastella G: Modification of some markers of inflammation during treatment for acute respiratory exacerbation in cystic fibrosis. Acta Paediatr. 1992, 81 (3): 227-230. 10.1111\/j.1651-2227.1992.tb12209.x.","journal-title":"Acta Paediatr"},{"issue":"4","key":"591_CR30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/ajcn\/64.4.635","volume":"64","author":"C Duggan","year":"1996","unstructured":"Duggan C, Colin AA, Agil A, Higgins L, Rifai N: Vitamin A status in acute exacerbations of cystic fibrosis. Am J Clin Nutr. 1996, 64 (4): 635-639.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"591_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1046\/j.1365-2362.2000.00667.x","volume":"30","author":"SC Bell","year":"2000","unstructured":"Bell SC, Bowerman AM, Nixon LE, Macdonald IA, Elborn JS, Shale DJ: Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis. Eur J Clin Invest. 2000, 30 (6): 553-559. 10.1046\/j.1365-2362.2000.00667.x.","journal-title":"Eur J Clin Invest"},{"key":"591_CR32","doi-asserted-by":"publisher","first-page":"S 225","DOI":"10.1086\/376525","volume":"37 Suppl 3","author":"DA Stevens","year":"2003","unstructured":"Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, Skov M, Maish W, Mastella G, participants in the Cystic Fibrosis Foundation Consensus Conference: Allergic bronchopulmonary aspergillosis in cystic fibrosis. State of the Art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis. 2003, 37 Suppl 3: S 225-64.","journal-title":"Clin Infect Dis"},{"key":"591_CR33","first-page":"S56","volume-title":"Journal of Cystic Fibrosis","author":"M Ibrahim","year":"2010","unstructured":"Ibrahim M, Elborn J, Rendall J, Parkins M: Clinical features and outcomes of cystic fibrosis pulmonary exacerbations presenting with normal inflammatory markers. Journal of Cystic Fibrosis. 2010, Oxford, UK: Elsevier, S56-"},{"issue":"12","key":"591_CR34","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest. 2003, 111 (12): 1805-1812. 10.1172\/JCI200318921.","journal-title":"J Clin Invest"},{"issue":"4","key":"591_CR35","doi-asserted-by":"publisher","first-page":"e62917","DOI":"10.1371\/journal.pone.0062917","volume":"8","author":"ET Zemanick","year":"2013","unstructured":"Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ, Accurso FJ, Laguna TA: Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One. 2013 Apr 30, 8 (4): e62917-10.1371\/journal.pone.0062917.","journal-title":"PLoS One"},{"issue":"Supl 1","key":"591_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0300-2896(05)70731-6","volume":"41","author":"R Cant\u00f3n","year":"2005","unstructured":"Cant\u00f3n R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S: Tratamiento antimicrobiano frente a la colonizaci\u00f3n pulmonar por Pseudomonas aeruginosa en el paciente con fibrosis qu\u00edstica. Arch Bronconeumol. 2005, 41 (Supl 1): 1-25.","journal-title":"Arch Bronconeumol"},{"key":"591_CR37","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ppul.20646","volume":"42","author":"DG Downey","year":"2007","unstructured":"Downey DG, Brockbank S, Martin SL, Ennis M, Elborn JS: The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation. Pediatr Pulmonol. 2007, 42: 729-735. 10.1002\/ppul.20646.","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"591_CR38","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ppul.21274","volume":"45","author":"SL Martin","year":"2010","unstructured":"Martin SL, Moffitt KL, McDowell A, Greenan C, Bright-Thomas RJ, Jones AM, Webb AK, Elborn JS: Association of airway cathepsin B and S with inflammation in cystic fibrosis. Pediatr Pulmonol. 2010 Sep, 45 (9): 860-68. 10.1002\/ppul.21274.","journal-title":"Pediatr Pulmonol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-14-150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2466-14-150\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-14-150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-14-150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:14:48Z","timestamp":1548216888000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/1471-2466-14-150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,23]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1186\/1471-2466-14-150","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,23]]},"assertion":[{"value":"26 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"150"}}